Ask a Patient Opinion Poll

As a condition of approval, should the FDA require that a new drug show how it performs compared with existing drugs approved for the same condition?

(Total Votes: 170)

Not sure (4.1%)
 

Yes (90.0%)
 

No (5.9%)
 


Voter Comments (the following are opinions of readers and not AskaPatient.com)

• people hope for miracles and then these drugs turn out harmful

• The patient should have the opportunit to choose. The Patient should have control.

• We spend too much money on similar drugs. A compaison would be very helpful.

• In addition, the "new" drug should have fewer side effects and be significantly better than the prio

• Certainly!

• All the truth, not just profit driven info.

• This could result in fewer and more costly approvals.

• Absolutely it should at the least be more effective and safer

• Medicine should be safe, not cause more harm.

• Without an accurate and valid comparison -- the public has no measurment as to any benefit of a new

• ALL side effects should also be evaluated before experimenting on the patient/public

• Testing only against placebo makes new drugs look goood even thought they may be worse than an old g

• Because there is no such thing as one size fits all with medications

• It should be tested against placebo and against alternatives, expecially GENERIC alternatives.

• Every new drug should be compared to the existing ligitimate comparables! Thats a given!

• New drug regulations are far too arbitrary already. I'd prefer a more stringent review overall.

• For example the old prozac arguably beats new versions.

• WE all TRUST the FDA -- they need to provide absolutely accurate info. to the public -- not specualt

• Should be compared against natural supplements.

• always!


Related Articles

Study finds including unpublished FDA data alters drug effectiveness outcomes

Comparative effectiveness approaches not always the most effective

Many New Drugs Did Not Have Comparative Effectiveness Information Available At Time Of FDA Approval

New drugs should be compared with existing treatments before approval, say experts